Real-World Clinical Outcomes with Biosimilar Nivolumab in Head and Neck Squamous Cell Carcinoma: A Single-Centre Retrospective Analysis (ESMO-IO 2026) - Oct 25, 2026 - Abstract #197P; Pres time: Dec 14, 2026; 05:30 PM - 06:30 PM; Location: Churchill Room; No abstract available
Clinical data • Real-world • Real-world evidence • Retrospective data • Head and Neck Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma of Head and Neck
|
|
Rajat Saha; Rashmi Bansal; Adhip Arora
|